If you require further searching capabilities for announcements please email: data@nzx.com
CEO and Governance Update 18 December 2025 Solution Dynamics’ CEO, Pat Brand, had today advised the Board that due to ongoing family medical issues he will step down from the CEO role at end December 2025. The Directors note Pat’s significant contributions in helping steer SDL through COVID, and continuing Nelson Siva’s legacy of transitioning SDL from a print/mail house towards an increasingly software-oriented organisation. Pat played an instrumental role in re-aligning the cost structure post the major customer RFP process in late 2024, plus leading the development of the nGAGE product, aimed at providing marketing and communication campaigns for the UK dental market. In a key milestone, the nGAGE pilot with several practice sites successfully went live overnight, testimony to six months of significant efforts and collaboration by teams in the UK and New Zealand. The product launch version of nGAGE is expected to be released before end of Q1 2026. The Board notes that Pat’s North American key customer relationships and market knowledge remain invaluable to SDL. He has agreed to join SDL’s Board as a Director from 1 January 2026 and will provide strategic input and support to international product and customer initiatives that are critical to the Company’s near-term growth prospects. From 1 January 2026, SDL’s CFO, Susie Watts, will assume the role of Acting CEO with executive support continuing from John McMahon and other directors as needed. The Company’s near-term focus remains on finalising the development and launch of nGAGE. There is significant early interest in nGAGE from corporate UK dental groups. Locally, SDL remains well positioned to capture share of Councils’ water billing communication requirements, as well as Australian local Council opportunities. The Company’s near-term objectives are to continue executing these opportunities. Susie has the full support of the Board and is well placed to ensure optimal outcomes. For further information: John McMahon Chair +64-(0)21-0914 0236